Bio Plus Co., Ltd (KOSDAQ:099430)
5,790.00
+10.00 (0.17%)
Apr 29, 2026, 9:50 AM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 355.70 billion as of April 28, 2026. Its market cap has decreased by -17.50% in one year.
Market Cap
355.70B
Enterprise Value
408.72B
Revenue
90.90B
Ranking
n/a
PE Ratio
38.79
Stock Price
5,790.00
Market Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 355.70B, a decrease of -21.20%. That is a compound annual growth rate of -5.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 355.70B | 14.91% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InBody Co.,Ltd | 406.81B |
| i-SENS | 625.67B |
| WON TECH | 689.13B |
| Curexo | 698.12B |
| ToolGen | 816.41B |
| DRTECH | 150.84B |
| T&R Biofab | 150.56B |
| Osang Healthcare Co.,Ltd | 127.51B |